DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration... Show more
a provider of healthcare, logistics and technical support services
Industry OfficeEquipmentSupplies
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EEIFX | 10.70 | 0.23 | +2.20% |
| Monteagle Enhanced Equity Income Instl | |||
| ACECX | 15.76 | 0.33 | +2.14% |
| American Century Emerging Markets C | |||
| APHIX | 34.71 | 0.08 | +0.23% |
| Artisan International Institutional | |||
| CHDEX | 14.79 | N/A | N/A |
| Cullen High Dividend Equity Retail | |||
| RRGCX | 8.26 | -0.06 | -0.72% |
| DWS RREEF Global Real Estate Secc C | |||
A.I.dvisor indicates that over the last year, DLHC has been loosely correlated with RGP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if DLHC jumps, then RGP could also see price increases.
| Ticker / NAME | Correlation To DLHC | 1D Price Change % | ||
|---|---|---|---|---|
| DLHC | 100% | -0.41% | ||
| RGP - DLHC | 38% Loosely correlated | +2.34% | ||
| GHC - DLHC | 36% Loosely correlated | -1.79% | ||
| MSA - DLHC | 35% Loosely correlated | +9.13% | ||
| FORR - DLHC | 33% Poorly correlated | +18.07% | ||
| FC - DLHC | 31% Poorly correlated | -0.33% | ||
More | ||||
| Ticker / NAME | Correlation To DLHC | 1D Price Change % |
|---|---|---|
| DLHC | 100% | -0.41% |
| Producer Manufacturing category (350 stocks) | -10% Poorly correlated | -0.09% |
| Office Equipment/Supplies category (45 stocks) | -12% Poorly correlated | +0.46% |
DLHC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 30 cases where DLHC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where DLHC's RSI Indicator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where DLHC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DLHC advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on July 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DLHC as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for DLHC turned negative on July 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at .
DLHC moved below its 50-day moving average on July 20, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DLHC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for DLHC entered a downward trend on July 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.758) is normal, around the industry mean (7.477). P/E Ratio (64.889) is within average values for comparable stocks, (73.658). DLHC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.519). DLHC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (0.279) is also within normal values, averaging (8.742).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. DLHC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DLHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.